Target intelligence / Profile preview

Poly(A) binding protein cytoplasmic 1 pseudogene 13 (PABPC1P13)

Target
PABPC1P13
Molecular classification
Other (pseudogene; related to Poly(A) binding proteins, but not itself a protein, receptor, enzyme, etc.)
01

Overview

Poly(A) binding protein cytoplasmic 1 pseudogene 13 (PABPC1P13) is a human pseudogene located in the genome and annotated by reference databases as a non-protein coding segment similar in sequence to the functional Poly(A) binding protein cytoplasmic 1 (PABPC1). Unlike PABPC1, PABPC1P13 does not encode a functional protein, is not involved in canonical biological processes, and is not considered a therapeutic target. Pseudogenes such as PABPC1P13 may have minor roles in gene regulation in rare contexts (for example, in some cancers)[8], but these roles are not established for this specific pseudogene and it is generally excluded from drug target databases[2][5].\n\nPABPC1P13 is not a functional protein, receptor, or enzyme.\nIt is not a drug target.\nThere are no known aliases beyond its canonical name and abbreviation.\nIt does not have established biological functions, disease roles, biomarkers, or safety concerns.\nIts sole classification is as a pseudogene related to poly(A) binding proteins[2][5].\n\nThis makes PABPC1P13 unsuitable for structured target annotation in pharmacology or molecular biology beyond identifying its status as a pseudogene.

Beyond the preview

Go deeper on Poly(A) binding protein cytoplasmic 1 pseudogene 13 (PABPC1P13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poly(A) binding protein cytoplasmic 1 pseudogene 13 (PABPC1P13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call